SCHEMBL22075927

SCHEMBL22075927

CCC(=O)N1CCCc2cc(OCC(=O)OC(C)(C)C)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.48
▸ TSHR P16473 4/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ MAPT P10636 3/20 0.47
▸ TP53 P04637 3/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ PDK1 Q15118 1/20 0.47
▸ PDK2 Q15119 1/20 0.47
▸ PDK3 Q15120 1/20 0.47
▸ PDK4 Q16654 1/20 0.47
▸ HTT P42858 2/20 0.46
▸ BRD4 O60885 1/20 0.46
▸ CREBBP Q92793 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30369865 0.90 MAPT (0.48) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL22075960 0.90 MAPT (0.48) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL24528787 0.89 MPO (0.50) ALDH1A1TSHRMAPK1NPSR1KMT2A
SCHEMBL29722743 0.89 MPO (0.50) ALDH1A1TSHRMAPK1NPSR1KMT2A
SCHEMBL29088763 0.89 HSD17B10 (0.49) ALDH1A1TSHRMAPK1KMT2AMEN1
SCHEMBL22075949 0.85 TSHR (0.56) ALDH1A1TSHRMAPK1LMNANPSR1
SCHEMBL30457883 0.84 ALDH1A1 (0.52) ALDH1A1TSHRMAPK1LMNANPSR1
SCHEMBL30457882 0.84 PDK1 (0.64) ALDH1A1TSHRMAPK1LMNANPSR1
SCHEMBL22075945 0.83 POLB (0.40) ALDH1A1TSHRMAPK1LMNANPSR1
SCHEMBL24764176 0.80 HSD17B10 (0.71) ALDH1A1TSHRMAPK1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-04 — — US disclosed
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-04 — — US disclosed
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-04 — — US disclosed
EP-3864030-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION The Scripps Research Institute (US) 2021-08-18 — — EP disclosed
US-20200190105-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed
US-20200190105-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190105-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION DCAF1, CUL4A, DCAF15 ALDH1A1 2600/4885TSHR 4158/4885MAPK1 3651/4885
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation DCAF1, CUL4A, DCAF15 ALDH1A1 2600/4885TSHR 4158/4885MAPK1 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback